CN105963295A - 吲哚-3-甲醇、二吲哚甲烷及其衍生物在制备治疗强直性脊柱炎物中的应用 - Google Patents
吲哚-3-甲醇、二吲哚甲烷及其衍生物在制备治疗强直性脊柱炎物中的应用 Download PDFInfo
- Publication number
- CN105963295A CN105963295A CN201610433556.9A CN201610433556A CN105963295A CN 105963295 A CN105963295 A CN 105963295A CN 201610433556 A CN201610433556 A CN 201610433556A CN 105963295 A CN105963295 A CN 105963295A
- Authority
- CN
- China
- Prior art keywords
- indole
- capsule
- radix
- derivative
- carbinol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- IVYPNXXAYMYVSP-UHFFFAOYSA-N indole-3-methanol Chemical compound C1=CC=C2C(CO)=CNC2=C1 IVYPNXXAYMYVSP-UHFFFAOYSA-N 0.000 title claims abstract description 37
- 206010002556 Ankylosing Spondylitis Diseases 0.000 title claims abstract description 24
- VFTRKSBEFQDZKX-UHFFFAOYSA-N 3,3'-diindolylmethane Chemical compound C1=CC=C2C(CC=3C4=CC=CC=C4NC=3)=CNC2=C1 VFTRKSBEFQDZKX-UHFFFAOYSA-N 0.000 title claims abstract description 15
- 239000003814 drug Substances 0.000 title claims abstract description 15
- 238000002360 preparation method Methods 0.000 title claims abstract description 15
- 229940079593 drug Drugs 0.000 title claims abstract description 14
- TWJAXIHBWPVMIR-UHFFFAOYSA-N diindolylmethane Natural products C1=CC=C2NC(CC=3NC4=CC=CC=C4C=3)=CC2=C1 TWJAXIHBWPVMIR-UHFFFAOYSA-N 0.000 title abstract 4
- 239000002775 capsule Substances 0.000 claims abstract description 58
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 11
- 239000004863 Frankincense Substances 0.000 claims abstract description 11
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims abstract description 7
- 210000000582 semen Anatomy 0.000 claims abstract description 7
- 239000000843 powder Substances 0.000 claims description 44
- RUMVKBSXRDGBGO-UHFFFAOYSA-N indole-3-carbinol Chemical compound C1=CC=C[C]2C(CO)=CN=C21 RUMVKBSXRDGBGO-UHFFFAOYSA-N 0.000 claims description 32
- 235000002279 indole-3-carbinol Nutrition 0.000 claims description 32
- 241001597008 Nomeidae Species 0.000 claims description 23
- 239000002671 adjuvant Substances 0.000 claims description 22
- XGDLHLISLBPXPR-UHFFFAOYSA-N C.C1=CC=C2NC=CC2=C1.C1=CC=C2NC=CC2=C1 Chemical compound C.C1=CC=C2NC=CC2=C1.C1=CC=C2NC=CC2=C1 XGDLHLISLBPXPR-UHFFFAOYSA-N 0.000 claims description 20
- 241000190633 Cordyceps Species 0.000 claims description 16
- 241000222336 Ganoderma Species 0.000 claims description 16
- 108010010803 Gelatin Proteins 0.000 claims description 16
- 239000008273 gelatin Substances 0.000 claims description 16
- 229920000159 gelatin Polymers 0.000 claims description 16
- 235000019322 gelatine Nutrition 0.000 claims description 16
- 235000011852 gelatine desserts Nutrition 0.000 claims description 16
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims description 16
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims description 16
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims description 16
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims description 16
- 239000007788 liquid Substances 0.000 claims description 16
- 238000010438 heat treatment Methods 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 241000717739 Boswellia sacra Species 0.000 claims description 10
- 239000002994 raw material Substances 0.000 claims description 8
- 238000003756 stirring Methods 0.000 claims description 8
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- 238000004140 cleaning Methods 0.000 claims description 4
- 238000001816 cooling Methods 0.000 claims description 4
- 238000002425 crystallisation Methods 0.000 claims description 4
- 230000008025 crystallization Effects 0.000 claims description 4
- 238000004090 dissolution Methods 0.000 claims description 4
- 238000001914 filtration Methods 0.000 claims description 4
- 230000004927 fusion Effects 0.000 claims description 4
- 238000000227 grinding Methods 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- 238000000465 moulding Methods 0.000 claims description 4
- 238000000746 purification Methods 0.000 claims description 4
- 238000005303 weighing Methods 0.000 claims description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 5
- 230000000694 effects Effects 0.000 abstract description 5
- 201000010099 disease Diseases 0.000 abstract description 4
- 208000024891 symptom Diseases 0.000 abstract description 4
- 239000008280 blood Substances 0.000 abstract description 3
- 210000004369 blood Anatomy 0.000 abstract description 3
- 230000017531 blood circulation Effects 0.000 abstract description 3
- 230000001737 promoting effect Effects 0.000 abstract description 3
- 238000010792 warming Methods 0.000 abstract description 3
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 2
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 2
- 235000017443 Hedysarum boreale Nutrition 0.000 abstract 2
- 235000007858 Hedysarum occidentale Nutrition 0.000 abstract 2
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 abstract 1
- 241001671653 Aconitum carmichaelii Species 0.000 abstract 1
- 241000382455 Angelica sinensis Species 0.000 abstract 1
- 235000003717 Boswellia sacra Nutrition 0.000 abstract 1
- 240000007551 Boswellia serrata Species 0.000 abstract 1
- 235000012035 Boswellia serrata Nutrition 0.000 abstract 1
- 241000208688 Eucommia Species 0.000 abstract 1
- 241000612166 Lysimachia Species 0.000 abstract 1
- 244000046146 Pueraria lobata Species 0.000 abstract 1
- 235000010575 Pueraria lobata Nutrition 0.000 abstract 1
- 229940116229 borneol Drugs 0.000 abstract 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 abstract 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- -1 semen strychni Chemical compound 0.000 abstract 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 210000003131 sacroiliac joint Anatomy 0.000 description 2
- 208000008822 Ankylosis Diseases 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 102000012153 HLA-B27 Antigen Human genes 0.000 description 1
- 108010061486 HLA-B27 Antigen Proteins 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010023198 Joint ankylosis Diseases 0.000 description 1
- 241000588748 Klebsiella Species 0.000 description 1
- 101000980463 Treponema pallidum (strain Nichols) Chaperonin GroEL Proteins 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000009172 bursting Effects 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 208000037893 chronic inflammatory disorder Diseases 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 210000001508 eye Anatomy 0.000 description 1
- 230000004761 fibrosis Effects 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 210000002356 skeleton Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A61K36/066—Clavicipitaceae
- A61K36/068—Cordyceps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/074—Ganoderma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/46—Eucommiaceae (Eucommia family), e.g. hardy rubber tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/486—Millettia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/56—Loganiaceae (Logania family), e.g. trumpetflower or pinkroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/714—Aconitum (monkshood)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material
- A61K9/4825—Proteins, e.g. gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Engineering & Computer Science (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
本发明公开了吲哚‑3‑甲醇、二吲哚甲烷及其衍生物在制备治疗强直性脊柱炎物中的应用以及一种吲哚‑3‑甲醇、二吲哚甲烷及其衍生物的胶囊制品。本发明配方更加简单,并且更加的科学合理,通过加入吲哚‑3‑甲醇、二吲哚甲烷、吲哚‑3‑甲醇衍生物和二吲哚甲烷衍生物,可以使得患者的强直性脊柱炎病情得到有效的抑制,减少患者因为病情所带来的痛苦,通过加入大四块瓦、甘草、杜仲、独活、当归、鸡血藤、肉桂、白芍、马钱子、梅花冰片、乳香、葛根、生川乌和生草的辅料,可以起到活血化瘀,温阳止痛,对治疗强直性脊柱炎有较好的治疗或缓解症状的作用,可以从根本上治疗强直性脊柱炎,具有良好的治疗效果。
Description
技术领域
本发明涉及生物医药技术领域,具体为吲哚-3-甲醇醇、二吲哚甲烷及其衍生物在制备治疗强直性脊柱炎物中的应用。
背景技术
强直性脊柱炎是以骶髂关节和脊柱附着点炎症为主要症状的疾病。与 HLA-B27 呈强关联。某些微生物 (如克雷白杆菌 )与易感者自身组织具有共同抗原,可引发异常免疫应答。是四肢大关节,以及椎间盘纤维环及其附近结缔组织纤维化和骨化,以及关节强直为病变特点的慢性炎性疾病。强直性脊柱炎属风湿病范畴,是血清阴性脊柱关节病的一种。该病病因尚不明确,是以脊柱为主要病变部位的慢性病,累及骶髂关节,引起脊柱强直和纤维化,造成不同程度眼、肺、肌肉、骨骼病变,属自身免疫性疾病。为此,急要开发出更多安全有效的治疗强直性脊柱炎的药物满足临床治疗的需要。
发明内容
本发明的目的在于提供吲哚-3-甲醇、二吲哚甲烷及其衍生物在制备治疗强直性脊柱炎物中的应用,以解决上述背景技术中提出的问题。
为实现上述目的,本发明提供如下技术方案:吲哚-3-甲醇、二吲哚甲烷及其衍生物在制备治疗强直性脊柱炎物中的应用。
优选的,该胶囊制品包括以下重量组份:吲哚-3-甲醇10-13份,二吲哚甲烷8-10份,吲哚-3-甲醇衍生物5-9份,二吲哚甲烷衍生物4-7份,辅料76-123份,空心胶囊制剂26-40份。
优选的,所述空心胶囊制剂包括以下重量组份:明胶7-12份、羟丙基甲基纤维素9-12份、虫草细粉6-9份,灵芝细粉4-7份。
优选的,所述辅料包括以下重量组份:大四块瓦5-8份,甘草6-9份,杜仲7-10份,独活4-7份,当归8-12份,鸡血藤5-9份,肉桂6-10份,白芍8-12份,马钱子5-7份,梅花冰片5-8份,乳香3-5份,葛根5-10份,生川乌6-9份,生草乌3-7份。
优选的,该胶囊制品通过以下步骤制得:
S1:胶囊外壳原料制作,将明胶、羟丙基甲基纤维素、虫草细粉和灵芝细粉均放入同一容器,且容器中放置有纯净水,将纯净水的温度加热到90-100摄氏度,并且对于明胶、羟丙基甲基纤维素、虫草细粉和灵芝细粉进行搅拌和溶解处理;
S2:胶囊模具清洁,把空心胶囊制作模具通过清洁装置清洁之后,再通过风晾干;
S3: 胶囊外壳制成,将搅拌均匀的于明胶、羟丙基甲基纤维素、虫草细粉和灵芝细粉的融合剂放入空心胶囊制作模具中,通过冷却装置,使得胶囊外壳冷却成型;
S4: 称量配比,将所需的原料按照一定的组分比例称量取用;
S5: 辅料溶液制作,将大四块瓦、甘草、杜仲、独活、当归、鸡血藤、肉桂、白芍、马钱子、梅花冰片、乳香、葛根、生川乌和生草一起放入加热器皿,且加热器皿中盛装有水,加热时间为48-72小时,并且对其进行搅拌,使其出现药渣;
S6:净化过滤,通过过滤装置把辅料溶液中的药渣过滤出来;
S7:药液制成,将吲哚-3-甲醇、二吲哚甲烷、吲哚-3-甲醇衍生物和二吲哚甲烷衍生物放入辅料溶液中进行均匀搅拌,搅拌均匀后得到药液;
S8: 药物粉末制作,将药液通过冷却装置冷却之后得到药液结晶,在通过研磨装置对其进行研磨,研磨之后再对于药物粉末进行称量;
S9:胶囊制作完成,把药物粉末按照要求放入胶囊外壳内部,胶囊制作完成。
与现有技术相比,本发明的有益效果是:该吲哚-3-甲醇、二吲哚甲烷及其衍生物在制备治疗强直性脊柱炎物中的应用,该配方更加简单,并且更加的科学合理,通过加入吲哚-3-甲醇、二吲哚甲烷、吲哚-3-甲醇衍生物和二吲哚甲烷衍生物,可以使得患者的强直性脊柱炎病情得到有效的抑制,减少患者因为病情所带来的痛苦,通过加入大四块瓦、甘草、杜仲、独活、当归、鸡血藤、肉桂、白芍、马钱子、梅花冰片、乳香、葛根、生川乌和生草的辅料,可以起到活血化瘀,温阳止痛,对治疗强直性脊柱炎有较好的治疗或缓解症状的作用,可以从根本上治疗强直性脊柱炎,具有良好的治疗效果。
具体实施方式
下面将结合本发明实施例中的技术方案进行清楚、完整地描述,显然,所描述的实施例仅仅是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。
本发明提供吲哚-3-甲醇、二吲哚甲烷及其衍生物在制备治疗强直性脊柱炎物中的应用技术方案:
实施例一
本发明提供一种技术方案:吲哚-3-甲醇、二吲哚甲烷及其衍生物在制备治疗强直性脊柱炎物中的应用。
该胶囊制品包括以下重量组份:吲哚-3-甲醇10-份,二吲哚甲烷8份,吲哚-3-甲醇衍生物5份,二吲哚甲烷衍生物4份,辅料76份,空心胶囊制剂26份。
空心胶囊制剂包括以下重量组份:明胶7份、羟丙基甲基纤维素9份、虫草细粉6份,灵芝细粉4份。
辅料包括以下重量组份:大四块瓦5份,甘草6份,杜仲7份,独活4份,当归8份,鸡血藤5份,肉桂6份,白芍8份,马钱子5份,梅花冰片5份,乳香3份,葛根5份,生川乌6份,生草乌3份。
该胶囊制品通过以下步骤制得:
S1:胶囊外壳原料制作,将明胶、羟丙基甲基纤维素、虫草细粉和灵芝细粉均放入同一容器,且容器中放置有纯净水,将纯净水的温度加热到90摄氏度,并且对于明胶、羟丙基甲基纤维素、虫草细粉和灵芝细粉进行搅拌和溶解处理;
S2:胶囊模具清洁,把空心胶囊制作模具通过清洁装置清洁之后,再通过风晾干;
S3: 胶囊外壳制成,将搅拌均匀的于明胶、羟丙基甲基纤维素、虫草细粉和灵芝细粉的融合剂放入空心胶囊制作模具中,通过冷却装置,使得胶囊外壳冷却成型;
S4: 称量配比,将所需的原料按照一定的组分比例称量取用;
S5: 辅料溶液制作,将大四块瓦、甘草、杜仲、独活、当归、鸡血藤、肉桂、白芍、马钱子、梅花冰片、乳香、葛根、生川乌和生草一起放入加热器皿,且加热器皿中盛装有水,加热时间为48小时,并且对其进行搅拌,使其出现药渣;
S6:净化过滤,通过过滤装置把辅料溶液中的药渣过滤出来;
S7:药液制成,将吲哚-3-甲醇、二吲哚甲烷、吲哚-3-甲醇衍生物和二吲哚甲烷衍生物放入辅料溶液中进行均匀搅拌,搅拌均匀后得到药液;
S8: 药物粉末制作,将药液通过冷却装置冷却之后得到药液结晶,在通过研磨装置对其进行研磨,研磨之后再对于药物粉末进行称量;
S9:胶囊制作完成,把药物粉末按照要求放入胶囊外壳内部,胶囊制作完成。
实施例二
本发明提供一种技术方案:吲哚-3-甲醇、二吲哚甲烷及其衍生物在制备治疗强直性脊柱炎物中的应用。
该胶囊制品包括以下重量组份:吲哚-3-甲醇13份,二吲哚甲烷10份,吲哚-3-甲醇衍生物9份,二吲哚甲烷衍生物7份,辅料123份,空心胶囊制剂40份。
优选的,空心胶囊制剂包括以下重量组份:明胶12份、羟丙基甲基纤维素12份、虫草细粉9份,灵芝细粉7份。
优选的,辅料包括以下重量组份:大四块瓦8份,甘草9份,杜仲10份,独活7份,当归12份,鸡血藤9份,肉桂10份,白芍12份,马钱子7份,梅花冰片8份,乳香5份,葛根10份,生川乌9份,生草乌7份。
优选的,该胶囊制品通过以下步骤制得:
S1:胶囊外壳原料制作,将明胶、羟丙基甲基纤维素、虫草细粉和灵芝细粉均放入同一容器,且容器中放置有纯净水,将纯净水的温度加热到100摄氏度,并且对于明胶、羟丙基甲基纤维素、虫草细粉和灵芝细粉进行搅拌和溶解处理;
S2:胶囊模具清洁,把空心胶囊制作模具通过清洁装置清洁之后,再通过风晾干;
S3: 胶囊外壳制成,将搅拌均匀的于明胶、羟丙基甲基纤维素、虫草细粉和灵芝细粉的融合剂放入空心胶囊制作模具中,通过冷却装置,使得胶囊外壳冷却成型;
S4: 称量配比,将所需的原料按照一定的组分比例称量取用;
S5: 辅料溶液制作,将大四块瓦、甘草、杜仲、独活、当归、鸡血藤、肉桂、白芍、马钱子、梅花冰片、乳香、葛根、生川乌和生草一起放入加热器皿,且加热器皿中盛装有水,加热时间为72小时,并且对其进行搅拌,使其出现药渣;
S6:净化过滤,通过过滤装置把辅料溶液中的药渣过滤出来;
S7:药液制成,将吲哚-3-甲醇、二吲哚甲烷、吲哚-3-甲醇衍生物和二吲哚甲烷衍生物放入辅料溶液中进行均匀搅拌,搅拌均匀后得到药液;
S8: 药物粉末制作,将药液通过冷却装置冷却之后得到药液结晶,在通过研磨装置对其进行研磨,研磨之后再对于药物粉末进行称量;
S9:胶囊制作完成,把药物粉末按照要求放入胶囊外壳内部,胶囊制作完成。
通过对上述两组实施例进行对比实验,能够发现,两组实施例均能够对患者的强直性脊柱炎起到一定的治疗效果,该配方更加简单,并且更加的科学合理,通过加入吲哚-3-甲醇、二吲哚甲烷、吲哚-3-甲醇衍生物和二吲哚甲烷衍生物,可以使得患者的强直性脊柱炎病情得到有效的抑制,减少患者因为病情所带来的痛苦,通过加入大四块瓦、甘草、杜仲、独活、当归、鸡血藤、肉桂、白芍、马钱子、梅花冰片、乳香、葛根、生川乌和生草的辅料,可以起到活血化瘀,温阳止痛,对治疗强直性脊柱炎有较好的治疗或缓解症状的作用,可以从根本上治疗强直性脊柱炎,具有良好的治疗效果。
尽管已经示出和描述了本发明的实施例,对于本领域的普通技术人员而言,可以理解在不脱离本发明的原理和精神的情况下可以对这些实施例进行多种变化、修改、替换和变型,本发明的范围由所附权利要求及其等同物限定。
Claims (5)
1.吲哚-3-甲醇、二吲哚甲烷及其衍生物在制备治疗强直性脊柱炎物中的应用。
2.根据权利要求1所述的吲哚-3-甲醇、二吲哚甲烷及其衍生物的胶囊制品,其特征在于:该胶囊制品包括以下重量组份:吲哚-3-甲醇10-13份,二吲哚甲烷8-10份,吲哚-3-甲醇衍生物5-9份,二吲哚甲烷衍生物4-7份,辅料76-123份,空心胶囊制剂26-40份。
3. 根据权利要求2所述的一种吲哚-3-甲醇、二吲哚甲烷及其衍生物的胶囊制品,其特征在于:所述空心胶囊制剂包括以下重量组份:明胶7-12份、羟丙基甲基纤维素9-12份、虫草细粉6-9份,灵芝细粉4-7份。
4.根据权利要求1所述的一种吲哚-3-甲醇、二吲哚甲烷及其衍生物的胶囊制品,其特征在于:所述辅料包括以下重量组份:大四块瓦5-8份,甘草6-9份,杜仲7-10份,独活4-7份,当归8-12份,鸡血藤5-9份,肉桂6-10份,白芍8-12份,马钱子5-7份,梅花冰片5-8份,乳香3-5份,葛根5-10份,生川乌6-9份,生草乌3-7份。
5.根据权利要求2或3或4所述的一种吲哚-3-甲醇、二吲哚甲烷及其衍生物的胶囊制品,其特征在于:该胶囊制品通过以下步骤制得:
S1:胶囊外壳原料制作,将明胶、羟丙基甲基纤维素、虫草细粉和灵芝细粉均放入同一容器,且容器中放置有纯净水,将纯净水的温度加热到90-100摄氏度,并且对于明胶、羟丙基甲基纤维素、虫草细粉和灵芝细粉进行搅拌和溶解处理;
S2:胶囊模具清洁,把空心胶囊制作模具通过清洁装置清洁之后,再通过风晾干;
S3: 胶囊外壳制成,将搅拌均匀的于明胶、羟丙基甲基纤维素、虫草细粉和灵芝细粉的融合剂放入空心胶囊制作模具中,通过冷却装置,使得胶囊外壳冷却成型;
S4: 称量配比,将所需的原料按照一定的组分比例称量取用;
S5: 辅料溶液制作,将大四块瓦、甘草、杜仲、独活、当归、鸡血藤、肉桂、白芍、马钱子、梅花冰片、乳香、葛根、生川乌和生草一起放入加热器皿,且加热器皿中盛装有水,加热时间为48-72小时,并且对其进行搅拌,使其出现药渣;
S6:净化过滤,通过过滤装置把辅料溶液中的药渣过滤出来;
S7:药液制成,将吲哚-3-甲醇、二吲哚甲烷、吲哚-3-甲醇衍生物和二吲哚甲烷衍生物放入辅料溶液中进行均匀搅拌,搅拌均匀后得到药液;
S8: 药物粉末制作,将药液通过冷却装置冷却之后得到药液结晶,在通过研磨装置对其进行研磨,研磨之后再对于药物粉末进行称量;
S9:胶囊制作完成,把药物粉末按照要求放入胶囊外壳内部,胶囊制作完成。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610433556.9A CN105963295A (zh) | 2016-06-18 | 2016-06-18 | 吲哚-3-甲醇、二吲哚甲烷及其衍生物在制备治疗强直性脊柱炎物中的应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610433556.9A CN105963295A (zh) | 2016-06-18 | 2016-06-18 | 吲哚-3-甲醇、二吲哚甲烷及其衍生物在制备治疗强直性脊柱炎物中的应用 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105963295A true CN105963295A (zh) | 2016-09-28 |
Family
ID=57021766
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610433556.9A Pending CN105963295A (zh) | 2016-06-18 | 2016-06-18 | 吲哚-3-甲醇、二吲哚甲烷及其衍生物在制备治疗强直性脊柱炎物中的应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105963295A (zh) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101940568A (zh) * | 2010-08-17 | 2011-01-12 | 合肥博太医药生物技术发展有限公司 | 吲哚-3-甲醇、二吲哚甲烷及其衍生物在制备治疗蒽环抗癌药引起的心脏衰竭药物中的应用 |
CN102370638A (zh) * | 2010-08-20 | 2012-03-14 | 南京大学 | 3,3’-二吲哚甲烷及衍生物在制备治疗肝脏疾病药物中的应用 |
CN104187649A (zh) * | 2014-08-18 | 2014-12-10 | 胡安然 | 强直性脊柱炎全营养配方食品 |
CN104740057A (zh) * | 2015-04-15 | 2015-07-01 | 淄博齐鼎立专利信息咨询有限公司 | 一种用于治疗强直性脊柱炎的中药组合物 |
-
2016
- 2016-06-18 CN CN201610433556.9A patent/CN105963295A/zh active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101940568A (zh) * | 2010-08-17 | 2011-01-12 | 合肥博太医药生物技术发展有限公司 | 吲哚-3-甲醇、二吲哚甲烷及其衍生物在制备治疗蒽环抗癌药引起的心脏衰竭药物中的应用 |
CN102370638A (zh) * | 2010-08-20 | 2012-03-14 | 南京大学 | 3,3’-二吲哚甲烷及衍生物在制备治疗肝脏疾病药物中的应用 |
CN104187649A (zh) * | 2014-08-18 | 2014-12-10 | 胡安然 | 强直性脊柱炎全营养配方食品 |
CN104740057A (zh) * | 2015-04-15 | 2015-07-01 | 淄博齐鼎立专利信息咨询有限公司 | 一种用于治疗强直性脊柱炎的中药组合物 |
Non-Patent Citations (1)
Title |
---|
汪建勋: "强直性脊柱炎中医药治疗优势", 《全国中西医结合强直性脊柱炎专题研讨会论文汇编》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102579774B (zh) | 一种用于治疗颈淋巴结核的中药组合物 | |
CN103446407A (zh) | 一种治疗颈腰椎病的纯中药制剂及其熏蒸剂 | |
CN103055278B (zh) | 一种治疗风湿类风湿的药物 | |
CN105963295A (zh) | 吲哚-3-甲醇、二吲哚甲烷及其衍生物在制备治疗强直性脊柱炎物中的应用 | |
CN103301402A (zh) | 治疗骨科疾病的中药制剂及其制备方法 | |
CN102266473A (zh) | 一种治疗系统性红斑狼疮的中药组合物 | |
CN101455829B (zh) | 一种泌尿系统的溶石排石中药胶囊 | |
CN101703710A (zh) | 治疗痛风病的中药制剂 | |
CN104435250A (zh) | 一种治疗精索静脉曲张的药物 | |
CN104096022A (zh) | 一种治疗强直性脊柱炎的外用复方中药制剂及其制备方法 | |
CN101224281B (zh) | 治疗皮肤化脓性炎症的中药制剂 | |
CN114010581A (zh) | 一种外用熏洗汤 | |
CN103007227B (zh) | 一种治疗肾结石的药物及其制备方法 | |
CN102657710A (zh) | 一种续筋骨治疗腰痛及腰椎间盘突出的药物及其制备方法 | |
CN102846741B (zh) | 一种治疗中风偏瘫后遗症的脐贴膏及其制备方法 | |
CN1954859B (zh) | 治疗慢性胆囊炎、胆绞痛的蒙药组合物及其方法 | |
CN103536822B (zh) | 治疗骨质增生及腰椎间盘突出的药物 | |
CN104116805A (zh) | 一种治疗盆腔淤血综合征的中药制剂 | |
CN101274027B (zh) | 一种治疗股骨头坏死的口服药、热敷散 | |
CN102205075B (zh) | 治疗乳腺病的外用药膏组合物的制备方法及其应用 | |
CN101314001A (zh) | 一种治疗血管性痴呆的中药组合物及其制备方法 | |
CN101474359A (zh) | 一种治疗痛风的苗药贴 | |
CN105250859A (zh) | 一种中草药膏及其制备方法 | |
CN104306585A (zh) | 一种用于治疗前列腺炎的中药组合物及其制备方法与应用 | |
CN103349692A (zh) | 一种治疗偏头痛、三叉神经疼痛的中药制剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20160928 |